Mutation of the Myosin Converter Domain Alters Cross-bridge Elasticity

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2002 Mar 21

PMID 11904418

Citations 48

Authors

Jan Kohler

Gerhard Winkler

Imke Schulte

Tim Scholz

William Mckenna

Bernhard Brenner

Theresia Kraft

Affiliations

Soon will be listed here.

Abstract

Elastic distortion of a structural element of the actomyosin complex is fundamental to the ability of myosin to generate motile forces. An elastic element allows strain to develop within the actomyosin complex (cross-bridge) before movement. Relief of this strain then drives filament sliding, or more generally, movement of a cargo. Even with the known crystal structure of the myosin head, however, the structural element of the actomyosin complex in which elastic distortion occurs remained unclear. To assign functional relevance to various structural elements of the myosin head, e.g., to identify the elastic element within the cross-bridge, we studied mechanical properties of muscle fibers from patients with familial hypertrophic cardiomyopathy with point mutations in the head domain of the beta-myosin heavy chain. We found that the Arg-719 --> Trp (Arg719Trp) mutation, which is located in the converter domain of the myosin head fragment, causes an increase in force generation and fiber stiffness under isometric conditions by 48-59%. Under rigor and relaxing conditions, fiber stiffness was 45-47% higher than in control fibers. Yet, kinetics of active cross-bridge cycling were unchanged. These findings, especially the increase in fiber stiffness under rigor conditions, indicate that cross-bridges with the Arg719Trp mutation are more resistant to elastic distortion. The data presented here strongly suggest that the converter domain that forms the junction between the catalytic and the light-chain-binding domain of the myosin head is not only essential for elastic distortion of the cross-bridge, but that the main elastic distortion may even occur within the converter domain itself.

Citing Articles

Myosin essential light chain 1sa decelerates actin and thin filament gliding on β-myosin molecules.

Osten J, Mohebbi M, Uta P, Matinmehr F, Wang T, Kraft T J Gen Physiol. 2022; 154(10).

PMID: 36053243 PMC: 9441736. DOI: 10.1085/jgp.202213149.

Myosin Heavy Chain Converter Domain Mutations Drive Early-Stage Changes in Extracellular Matrix Dynamics in Hypertrophic Cardiomyopathy.

Hsieh J, Becklin K, Givens S, Komosa E, Abrahante Llorens J, Kamdar F Front Cell Dev Biol. 2022; 10:894635.

PMID: 35784482 PMC: 9245526. DOI: 10.3389/fcell.2022.894635.

Cardiac ventricular myosin and slow skeletal myosin exhibit dissimilar chemomechanical properties despite bearing the same myosin heavy chain isoform.

Wang T, Spahiu E, Osten J, Behrens F, Grunhagen F, Scholz T J Biol Chem. 2022; 298(7):102070.

PMID: 35623390 PMC: 9243179. DOI: 10.1016/j.jbc.2022.102070.

Muscle LIM Protein Force-Sensing Mediates Sarcomeric Biomechanical Signaling in Human Familial Hypertrophic Cardiomyopathy.

Riaz M, Park J, Sewanan L, Ren Y, Schwan J, Das S Circulation. 2022; 145(16):1238-1253.

PMID: 35384713 PMC: 9109819. DOI: 10.1161/CIRCULATIONAHA.121.056265.

Critical Evaluation of Current Hypotheses for the Pathogenesis of Hypertrophic Cardiomyopathy.

Usaj M, Moretto L, Mansson A Int J Mol Sci. 2022; 23(4).

PMID: 35216312 PMC: 8880276. DOI: 10.3390/ijms23042195.

References

Higuchi H, Yanagida T, Goldman Y . Compliance of thin filaments in skinned fibers of rabbit skeletal muscle. Biophys J. 1995; 69(3):1000-10. PMC: 1236329. DOI: 10.1016/S0006-3495(95)79975-1. View

Kraft T, Brenner B . Force enhancement without changes in cross-bridge turnover kinetics: the effect of EMD 57033. Biophys J. 1997; 72(1):272-81. PMC: 1184316. DOI: 10.1016/S0006-3495(97)78666-1. View

Whittaker M, Smith J, Faust L, Milligan R, Sweeney H . A 35-A movement of smooth muscle myosin on ADP release. Nature. 1995; 378(6558):748-51. DOI: 10.1038/378748a0. View

Nier V, Schultz I, Brenner B, FORSSMANN W, Raida M . Variability in the ratio of mutant to wildtype myosin heavy chain present in the soleus muscle of patients with familial hypertrophic cardiomyopathy. A new approach for the quantification of mutant to wildtype protein. FEBS Lett. 1999; 461(3):246-52. DOI: 10.1016/s0014-5793(99)01433-7. View

Thedinga E, Karim N, Kraft T, Brenner B . A single-fiber in vitro motility assay. In vitro sliding velocity of F-actin vs. unloaded shortening velocity in skinned muscle fibers. J Muscle Res Cell Motil. 2000; 20(8):785-96. DOI: 10.1023/a:1005658825375. View

Geeves M, Holmes K . Structural mechanism of muscle contraction. Annu Rev Biochem. 2000; 68:687-728. DOI: 10.1146/annurev.biochem.68.1.687. View

Irving M, Piazzesi G, Lucii L, Sun Y, Harford J, Dobbie I . Conformation of the myosin motor during force generation in skeletal muscle. Nat Struct Biol. 2000; 7(6):482-5. PMC: 8397617. DOI: 10.1038/75890. View

Yamashita H, Tyska M, Warshaw D, LOWEY S, Trybus K . Functional consequences of mutations in the smooth muscle myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy. J Biol Chem. 2000; 275(36):28045-52. DOI: 10.1074/jbc.M005485200. View

Enjuto M, Francino A, Navarro-Lopez F, Viles D, Pare J, Ballesta A . Malignant hypertrophic cardiomyopathy caused by the Arg723Gly mutation in beta-myosin heavy chain gene. J Mol Cell Cardiol. 2000; 32(12):2307-13. DOI: 10.1006/jmcc.2000.1260. View

10.

Kubis H, Gros G . A rapid electrophoretic method for separating rabbit skeletal muscle myosin heavy chains at high resolution. Electrophoresis. 1997; 18(1):64-6. DOI: 10.1002/elps.1150180113. View

11.

Fujita H, Sugiura S, Momomura S, Omata M, Sugi H, Sutoh K . Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication. J Clin Invest. 1997; 99(5):1010-5. PMC: 507909. DOI: 10.1172/JCI119228. View

12.

Malinchik S, Cuda G, PODOLSKY R, Horowits R . Isometric tension and mutant myosin heavy chain content in single skeletal myofibers from hypertrophic cardiomyopathy patients. J Mol Cell Cardiol. 1997; 29(2):667-76. DOI: 10.1006/jmcc.1996.0309. View

13.

Dominguez R, Freyzon Y, Trybus K, Cohen C . Crystal structure of a vertebrate smooth muscle myosin motor domain and its complex with the essential light chain: visualization of the pre-power stroke state. Cell. 1998; 94(5):559-71. DOI: 10.1016/s0092-8674(00)81598-6. View

14.

Bonne G, Carrier L, Richard P, Hainque B, Schwartz K . Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ Res. 1998; 83(6):580-93. DOI: 10.1161/01.res.83.6.580. View

15.

Dobbie I, Linari M, Piazzesi G, Reconditi M, Koubassova N, Ferenczi M . Elastic bending and active tilting of myosin heads during muscle contraction. Nature. 1998; 396(6709):383-7. DOI: 10.1038/24647. View

16.

Kraft T, Xu S, Brenner B, Yu L . The effect of thin filament activation on the attachment of weak binding cross-bridges: A two-dimensional x-ray diffraction study on single muscle fibers. Biophys J. 1999; 76(3):1494-513. PMC: 1300126. DOI: 10.1016/S0006-3495(99)77309-1. View

17.

Houdusse A, Kalabokis V, Himmel D, Szent-Gyorgyi A, Cohen C . Atomic structure of scallop myosin subfragment S1 complexed with MgADP: a novel conformation of the myosin head. Cell. 1999; 97(4):459-70. DOI: 10.1016/s0092-8674(00)80756-4. View

18.

Corrie J, Brandmeier B, Ferguson R, Trentham D, Kendrick-Jones J, Hopkins S . Dynamic measurement of myosin light-chain-domain tilt and twist in muscle contraction. Nature. 1999; 400(6743):425-30. DOI: 10.1038/22704. View

19.

HUXLEY A . Muscle structure and theories of contraction. Prog Biophys Biophys Chem. 1957; 7:255-318. View

20.

HUXLEY A . Muscular contraction. J Physiol. 1974; 243(1):1-43. PMC: 1330687. View